Psychiatry and Neurology, Neurology · Little Rock, AR
NPI
1932380185
Since 2007
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
4301 W Markham St, Slot 500
Little Rock, AR, 72205
Phone (501) 526-6169
Groups this clinician bills Medicare through
Medicare paid, 2024
$50K
931 services
Medicare patients, 2024
232
Average age 72
Drug cost, 2024
$1.0M
1,859 prescriptions
Company payments, 2024
$313
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Tuhin Virmani was code 95874 (musculoskeletal), 139 times for 51 patients. In total Tuhin Virmani billed 931 services in 25 codes, and Medicare paid $50K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-07-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95874 Musculoskeletal | Facility | 139 | 51 | $13.01 | $1,808 |
| 99213 Office E&M - Established | Facility | 130 | 78 | $41.57 | $5,405 |
| 99214 Office E&M - Established | Facility | 103 | 82 | $59.75 | $6,154 |
| 64616 Musculoskeletal | Facility | 93 | 32 | $98.16 | $9,128 |
| 64642 Musculoskeletal | Facility | 73 | 23 | $59.30 | $4,329 |
| 99215 Office E&M - Established | Facility | 62 | 45 | $97.95 | $6,073 |
| 99232 Hospital E&M - Subsequent | Facility | 47 | 22 | $55.48 | $2,607 |
| 64643 Musculoskeletal | Facility | 36 | 11 | $45.91 | $1,653 |
| 95983 Electrical Nerve Conductivity | Facility | 33 | 18 | $29.62 | $977 |
| 95970 Electrical Nerve Conductivity | Facility | 30 | 22 | $12.24 | $367 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 22 | 17 | $21.70 | $477 |
| 99222 Hospital E&M - Initial | Facility | 21 | 21 | $94.01 | $1,974 |
| 99212 Office E&M - Established | Facility | 15 | 11 | $23.83 | $357 |
| 99205 Office E&M - New | Facility | 14 | 14 | $120.92 | $1,693 |
| 99204 Office E&M - New | Facility | 11 | 11 | $96.16 | $1,058 |
By year: 2022 $47K for 937 services; 2023 $47K for 908 services; 2024 $50K for 931 services.
Medicare prescription drug claims, 2024
In 2024, the drug Tuhin Virmani prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 305 prescriptions and refills. In total Tuhin Virmani wrote 1,859 Medicare prescriptions that cost $1.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 305 | 638 | 93 | $17K |
| Rytary Carbidopa/Levodopa | 205 | 218 | 24 | $244K |
| Clonazepam Generic | 173 | 221 | 25 | $1,015 |
| Selegiline Hcl Generic | 113 | 182 | 21 | $11K |
| Quetiapine Fumarate Generic | 80 | 134 | 16 | $930 |
| Amantadine Amantadine Hcl | 69 | 125 | 18 | $3,014 |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 58 | 135 | 16 | $2,889 |
| Nourianz Istradefylline | 52 | 59 | Under 11 | $109K |
| Citalopram Hbr Citalopram Hydrobromide | 41 | 83 | 12 | $197 |
| Primidone Generic | 40 | 83 | 11 | $898 |
| Clozapine Generic | 40 | 40 | Under 11 | $447 |
| Austedo Deutetrabenazine | 39 | 39 | Under 11 | $328K |
| Mirtazapine Generic | 37 | 80 | 11 | $376 |
| Gabapentin Generic | 36 | 58 | Under 11 | $510 |
| Donepezil Hcl Generic | 36 | 86 | 17 | $359 |
Brand drugs: 359 claims; generic drugs: 1,500 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Tuhin Virmani $313 ($313 in general payments such as food, travel and fees) from 1 company. The largest payer was Saluda Medical Americas, Inc. with $313.
| Company | Payments | Amount |
|---|---|---|
| Saluda Medical Americas, Inc. | 1 | $313 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.